Devices and methods for treating lung diseases
Pulmonary treatment methods and systems. During pulmonary treatment breath cycles, a hold period of elevated inspiration pressure may promote lung region filling (and potentially recruitment) via collateral airways. Expectoration is promoted by dropping from the inspiration pressure to an undershoot pressure; de-recruitment (e.g., by airway collapse) is mitigated by raising the undershoot pressure to a positive expiratory pressure (PEP) during expiration phase. Breath cycles with a period of post-PEP suction may also be administered. Respiratory therapy systems may be programmed or re-programmed to administer this pressure protocol. In some embodiments, a system includes a hand-held unit including a patient mouthpiece, a base unit which provides pressurized gas to the mouthpiece, an electronically controllable valve in the hand-held unit for providing therapy maneuvers such as PEP (Positive Expiratory Pressure) through the mouthpiece, and a computing unit which instructs the hand-held unit to perform therapy maneuvers.
1. A method of using pressure to recruit lung regions of a patient, the method comprising administering, during each of one or more breath cycles:
during an inspiratory phase, providing a period of positive inspiration pressure extended to pressurize de-recruited lung regions via collateral airways;
during an expiratory phase, providing a reduction from the positive inspiration pressure down to a non-negative undershoot pressure, allowing pressure in pressurized de-recruited lung regions to mobilize mucous along main branch airways of the lung; and
providing an elevation of pressure from the undershoot pressure to a positive expiratory pressure, before lung volume reaches a breath cycle minimum; wherein:
within a first one or more administrations during said one or more breath cycles, the positive expiratory pressure is followed by initiation of a next inspiratory phase without suction; and
within a second one or more administrations during said one or more breath cycles following the first one or more administrations, the positive expiratory pressure is followed by a period of suction before the next inspiratory phase.
2. The method according to claim 1 , wherein, after a decrease in pressure and during the expiratory phase, gradually increasing positive expiratory pressure through a range of pressures comprising a lower pressure, an upper pressure and the positive expiratory pressure.
3. The method according to claim 1 , comprising, after the reduction from the positive inspiration pressure and during the expiratory phase, before lungs of the patient reach a minimum volume during the expiratory phase, increasing pressure to a positive expiratory pressure within a range between about 5 cm H 2 O and 9 cm H 2 O.
4. The method according to claim 1 , wherein providing pressure is performed by a device selected from a group consisting of:
a respiratory ventilator;
a cough simulation device;
a cough assistance system; and
a mechanical insufflation-exsufflation device.
5. The method according to claim 1 , wherein during the inspiratory phase, positive inspiration pressure is maintained within a range of about 30-50 cm H 2 O of pressure for a high positive pressure period between about 0.8 seconds and 5 seconds, after an inspirium rump period.
6. The method according to claim 1 , wherein during the inspiratory phase, maintaining pressure within a range of about 8-40 cm H 2 O of pressure for a hold period between about 1-3 seconds.
7. The method according to claim 1 , wherein at onset of the expiratory phase comprising decreasing pressure to a minimum pressure below 5 cm H 2 O.
8. The method according to claim 1 , comprising:
decreasing pressure within said second one or more administrations to a first range of expiratory pressures for a period including at least 1.5 seconds at a positive expiratory pressure at onset of the expiratory phase; and
followed by, during a suction period within said second one or more administrations, decreasing pressure to a suction pressure within a range between about −20 cm H 2 O and about −40 cm H 2 O.
9. The method according to claim 1 , wherein the positive expiratory pressure is maintained for 2-3.5 seconds after the onset of the expiratory phase until the next inspiratory phase begins.
10. The method according to claim 1 , wherein the undershoot pressure is above about 0 cm H 2 O.
11. The method according to claim 1 , wherein the positive expiratory pressure within said second one or more administrations is maintained for 0.5-2.5 seconds, and is followed by suction to a pressure within a range of −20 to −40 cm H 2 O before the next inspiratory phase begins.
12. The method according to claim 1 wherein:
within the first one or more administrations during said one or more breath cycles, the positive expiratory pressure is maintained for 2-3.5 seconds after the onset of the expiratory phase until the next inspiratory phase begins; and
within the second one or more administrations during said one or more breath cycles following the first one or more administrations, the positive expiratory pressure is maintained for 0.5-2.5 seconds after the onset of the expiratory phase, and is followed by suction to a pressure within a range of −20 to −40 cm H 2 O before the next inspiratory phase begins.
13. The method according to claim 1 , comprising beginning or interrupting the administering based on monitoring pulmonary pressure using a sensor, and based on detecting a spontaneous change in sensed pulmonary pressure.
14. The method according to claim 1 , comprising, during a sequence of breaths, and following said one or more breath cycles comprising administrations, administering over another one or more breath cycles a medication mode of pulmonary therapy applying medicine to the lungs, comprising an inhalation phase and an expiratory phase; and
wherein, during the inhalation phase of the medication mode of pulmonary therapy, maintaining pressure within a range of about 8-40 cm H 2 O of pressure for a period between about 1-3 seconds, during which said inspiratory phase medicine is released to the lungs.
15. The method according to claim 14 , wherein, at onset of an expiratory phase of the medication mode of pulmonary therapy, decreasing pressure to a positive expiratory pressure lower than pressure at the inhalation phase, and within a range between about 1 cm H 2 O and 8 cm H 2 O.
16. The method according to claim 14 , wherein, the medicine is released to the lungs 1-3 seconds after initiation of the inhalation phase.
17. A system for collecting pulmonary data from patients and providing pulmonary physical treatment, the system comprising:
a pulmonary sensor;
a computing unit arranged to receive data measured by the pulmonary sensor and analyze the data, producing an analysis; and
a pulmonary physical treatment unit for providing pulmonary physical treatment under control by the computing unit,
wherein the computing unit is arranged to:
control the pulmonary physical treatment unit to provide pulmonary physical treatment based on the data, administering, during each of one or more breath cycles, treatment as follows:
during an inspiratory phase, a period of positive inspiration pressure extended to pressurize de-recruited lung regions via collateral airways;
during an expiratory phase, a reduction from the positive inspiration pressure down to a non-negative undershoot pressure, allowing pressure in pressurized de-recruited lung regions to mobilize mucous along main branch airways of the lung; and
elevation of pressure from the undershoot pressure to a positive expiratory pressure, before lung volume reaches a breath cycle minimum; wherein
within a first one or more administrations during said one or more breath cycles, the positive expiratory pressure is followed by initiation of a next inspiratory phase without suction, and
within a second one or more administrations during said one or more breath cycles following the first one or more administrations, the positive expiratory pressure is followed by a period of suction before the next inspiratory phase.
18. A system according to claim 17 , comprising an electronically controllable valve in a hand-held unit, configured to be controllable for providing PEP (Positive Expiratory Pressure) maneuvers to the patient via a mouthpiece.
19. A system according to claim 17 , comprising a pulmonary medicine unit configured for dispensing pulmonary medicine under control of the computing unit, wherein the computing unit is arranged to determine whether to control the pulmonary medicine unit to provide pulmonary medicine based on the analysis.
20. A method according to claim 1 , wherein the undershoot pressure is high enough to avoid collapse of said pressurized de-recruited lung regions and causes pressure in said de-recruited lung regions to mobilize mucous along main branch airways of the lung.
21. A method according to claim 1 , further comprising:
identifying a patient with de-recruited lung regions and unsatisfactory mucus clearing;
administering, during each of said one or more breath cycles said period of positive inspiration pressure followed by said reduction from the positive inspiration pressure down to said non-negative undershoot pressure and followed by said elevation of pressure from the undershoot pressure.
22. A method according to claim 1 , wherein said elevation of pressure continues gradually for between 1.5 and 3.5 seconds before the lung volume reaches a minimum.